SLC22A3 and myelodysplastic syndrome: To verify the regulatory role of SLC22A3 methylation in AML pathogenesis, specimens of newly diagnosed MDS (n = 20) and AML (n = 89) were used to assess SLC22A3 expression level by RT-qPCR.